Stock Analysis on Net
Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

Balance Sheet: Assets
Quarterly Data

Beginner level

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Merck & Co. Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Cash and cash equivalents 7,356  11,103  7,425  9,676  7,869  6,659  8,076  7,965  7,826  5,310  4,483  6,092  7,901  7,786  11,708  6,515  7,907  6,608  9,716  8,524  7,548  6,922  7,980 
Short-term investments —  —  774  149  446  722  899  2,459  2,284  2,863  2,406  3,294  4,181  3,541  7,826  5,160  5,226  3,227  4,903  4,541  4,448  7,621 
Accounts receivable, net of allowance for doubtful accounts 8,422  7,577  8,182  6,778  8,442  7,964  7,608  7,071  7,374  7,287  7,245  6,873  7,671  7,439  7,066  7,018  7,364  6,916  6,850  6,484  6,414  6,510  6,670 
Inventories, excludes inventories classified in Other assets 6,128  6,056  5,846  5,978  5,855  5,847  5,712  5,440  5,416  5,178  5,382  5,096  5,263  5,407  5,146  4,866  5,244  5,248  5,102  4,700  5,123  5,306  5,539 
Other current assets 4,671  4,607  4,714  4,277  3,827  3,382  3,233  4,500  3,761  4,005  4,112  4,299  3,790  3,354  4,069  4,389  3,765  3,928  3,877  5,153  4,941  5,133  5,117 
Current assets 26,577  29,343  26,174  27,483  26,142  24,298  25,351  25,875  26,836  24,064  24,085  24,766  27,919  28,167  31,530  30,614  29,440  27,926  28,772  29,764  28,567  28,319  32,927 
Investments 1,372  1,251  555  1,469  2,111  3,779  5,621  6,233  7,606  10,033  11,033  12,125  12,206  12,138  11,896  11,416  11,657  11,879  12,554  13,039  13,080  13,333  13,092 
Property, plant and equipment, at cost, net of accumulated depreciation 16,919  15,789  15,269  15,053  14,287  13,862  13,506  13,291  12,755  12,626  12,561  12,439  12,189  12,094  12,042  12,026  12,029  11,987  12,360  12,507  12,482  12,630  12,910 
Goodwill 20,248  20,067  19,767  19,425  19,480  19,490  18,170  18,253  18,258  18,274  18,304  18,284  18,340  18,358  18,358  18,162  18,260  17,809  17,784  17,723  17,761  17,707  17,740 
Other intangibles, net 16,677  16,566  16,096  14,196  12,307  13,381  10,999  11,431  12,175  12,898  13,500  14,183  15,138  16,119  16,863  17,305  20,506  20,315  21,364  22,602  23,724  24,750  26,080 
Other assets 8,007  7,599  7,052  6,771  9,004  9,155  8,707  7,554  7,500  7,145  6,558  6,075  5,884  5,928  5,872  5,854  6,443  6,559  5,921  6,144  5,618  5,843  5,596 
Noncurrent assets 63,223  61,272  58,739  56,914  57,189  59,667  57,003  56,762  58,294  60,976  61,956  63,106  63,757  64,637  65,031  64,763  68,895  68,549  69,983  72,015  72,665  74,263  75,418 
Total assets 89,800  90,615  84,913  84,397  83,331  83,965  82,354  82,637  85,130  85,040  86,041  87,872  91,676  92,804  96,561  95,377  98,335  96,475  98,755  101,779  101,232  102,582  108,345 

Based on: 10-Q (filing date: 2020-11-05), 10-Q (filing date: 2020-08-05), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-05), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-08), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-06), 10-Q (filing date: 2018-08-07), 10-Q (filing date: 2018-05-08), 10-K (filing date: 2018-02-27), 10-Q (filing date: 2017-11-07), 10-Q (filing date: 2017-08-08), 10-Q (filing date: 2017-05-09), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-07), 10-Q (filing date: 2016-08-08), 10-Q (filing date: 2016-05-09), 10-K (filing date: 2016-02-26), 10-Q (filing date: 2015-11-05), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-07).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Merck & Co. Inc.’s current assets increased from Q1 2020 to Q2 2020 but then slightly decreased from Q2 2020 to Q3 2020 not reaching Q1 2020 level.
Property, plant and equipment, at cost, net of accumulated depreciation Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Merck & Co. Inc.’s property, plant and equipment, at cost, net of accumulated depreciation increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Merck & Co. Inc.’s noncurrent assets increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Merck & Co. Inc.’s total assets increased from Q1 2020 to Q2 2020 but then slightly decreased from Q2 2020 to Q3 2020.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Merck & Co. Inc.’s cash and cash equivalents increased from Q1 2020 to Q2 2020 but then decreased significantly from Q2 2020 to Q3 2020.
Short-term investments Amount of investment in marketable security, classified as current.
Accounts receivable, net of allowance for doubtful accounts Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Merck & Co. Inc.’s accounts receivable, net of allowance for doubtful accounts decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.
Inventories, excludes inventories classified in Other assets Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Merck & Co. Inc.’s inventories, excludes inventories classified in Other assets increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.